Early Ultrasound Evaluation Identifies Excellent Responders to Neoadjuvant Systemic Therapy in Patients with Triple Negative Breast Cancer

BACKGROUND: Heterogeneity exists in triple negative breast cancer (TNBC) response to standard anthracycline/taxane based neoadjuvant systemic therapy (NAST) with 40–50% of patients having pathologic complete response to therapy (pCR). Early assessment of imaging response during NAST may identify a s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Adrada, Beatriz E., Candelaria, Rosalind, Moulder, Stacy, Thompson, Alastair, Wei, Peng, Whitman, Gary J., Valero, Vicente, Litton, Jennifer K., Santiago, Lumarie, Scoggins, Marion E., Moseley, Tanya, White, Jason B, Ravenberg, Elizabeth. E, Yang, Wei T., Rauch, Gaiane M.
Format: Artigo
Idioma:Inglês
Publicat: 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319084/
https://ncbi.nlm.nih.gov/pubmed/33878210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars